Search

everythinglearnresearchcommunity

for

Search:↓

The user shared their successful hair regrowth journey using a combination of oral Dutasteride and a topical mix of Finasteride, Minoxidil, Tretinoin, and Ketoconazole. They experienced no side effects and noted significant improvement, except for one persistent thinning area.

User asks about Pyrilutamide release in Europe, specifically Germany, and considers importing it from China. No specific treatments mentioned.

The conversation discusses the potential use of verteporfin for hair loss treatment, with one user mentioning their surgeon's interest in trying it and another noting its research status and clinical use as a YAP inhibitor. Some users debate the market size, availability of generics, and the optimism in the hair loss community regarding new treatments.

Shiseido's S-DSC hair regenerative treatment in Japan focuses on improving existing hair by thickening miniaturized follicles, not creating new ones. There is limited patient feedback and long-term data available.

PP405 is a potential hair loss treatment that may work by blocking signals that cause hair cells to stop growing, requiring daily application for effectiveness. It could serve as an alternative to minoxidil and finasteride, but it is not yet available on the market and may take several years to be released.

The post is about the potential legal trouble of bringing a four-month supply of fluridil, a hair loss treatment, into non-Western countries.

The conversation discusses hair loss treatments, focusing on a new slow-release oral minoxidil compared to topical minoxidil and finasteride. The results show that twice-daily dosing of the new treatment is slightly more effective than once-daily, but concerns about cost, side effects, and the accuracy of reported results remain.

A 26-year-old with extreme male pattern baldness saw hair regrowth after 6 months using Minoxidil, Finasteride, microneedling, Nizoral, a vitamin complex, biotin, and a shampoo with baicapil. Continuation of treatment is necessary to maintain results; stopping may lead to hair loss, making a hair transplant a potential future option.

The user experienced significant hair regrowth using topical minoxidil 5% twice daily and 1mg finasteride daily, along with microstamping every 14 days. They reported initial shedding but achieved satisfying results by month four, with minimal side effects.

Clascoterone solution is in Phase III trials for male androgenetic alopecia, with results expected in the second half of 2025. Commercialization is anticipated in about 2-3 years, but there are concerns about delays and market expectations.

The user is considering switching to oral dutasteride and oral minoxidil after being happy with their 4.5-month hair loss treatment progress using oral and topical finasteride, topical minoxidil, tretinoin, and microneedling. They thanked the community for information on medications.

RU58841 lacks FDA approval due to financial and safety concerns, including potential cardiological side effects. The company abandoned further research, and users report adverse effects like heart palpitations and gynecomastia.

The conversation discusses using a 4-in-1 spray containing minoxidil, tretinoin, caffeine, and melatonin for hair loss. Users consider the potential benefits of combining these ingredients, with some interest in a comprehensive approach to treatment.

The conversation discusses hair loss treatments, specifically the use of oral Minoxidil 5mg and Finasteride 1mg, with users sharing their experiences and progress. The original poster reports no side effects and noticeable progress after four months of treatment.

The user experienced hair regrowth using topical finasteride 1% and minoxidil 5% over four months, with no side effects and improved hair density. They initially experienced shedding, which was followed by regrowth, and they stopped dermarolling due to concerns about damaging new growth.

Pelage Pharmaceuticals raised $120M for their hair loss treatment, PP405, showing strong investor confidence despite limited data. There is skepticism about its efficacy and long-term effects compared to treatments like GT20029.

A user shared their 4-year progress using finasteride (1 mg) and 11 months of oral minoxidil (2.5 mg) for hair loss. They reported thicker, better-quality hair with no side effects and plan to continue the regimen, possibly adding micro-needling and dutasteride.

The discussion is about a hair loss drug called pyrilutamide. Users discuss its efficacy, safety, and expected market release around 2025-2026, with some expressing concerns about the authenticity of current market offerings.

PP405 increased hair density by 20% in 31% of participants, but results are considered underwhelming. Minoxidil and finasteride are seen as more effective treatments.

PP405 is likely a scam, with concerns about its legitimacy and safety, as it may cause unintended tissue growth. Users suggest sticking to known treatments like finasteride and minoxidil.

The user has been using 1mg oral finasteride daily for four years, experiencing significant hair regrowth and increased testosterone levels without negative side effects. They advise patience and monitoring for side effects, noting that their hair continues to improve with this treatment.

New hair loss treatments, including Breezula, VDPHL01, and PP405, are nearing Phase 3 trials, offering hope for effective solutions. Current treatments like finasteride and minoxidil remain effective, but early intervention is crucial.

The conversation is about hair loss treatment progress using a combination of 0.1% finasteride, 0.025% tretinoin solution, and 2.5mg oral minoxidil. Users express positive reactions and hope for similar results.

The user plans to dermaroll and use minoxidil for hair loss over the next 4 months, documenting progress monthly. They will also consider finasteride later and include vitamins, a custom shampoo, castor oil, scalp massages, and increased water intake in their regimen.

Hair loss discussion includes treatments like Minoxidil, Finasteride, and RU58841. Eucapil (fluridil) is approved as a cosmetic hair-care agent in Europe, but users question the level of testing required for approval.

A person shared their hair transplant experience at Diamond Hair Clinic, discussing the process, costs, and satisfaction with the results. They used Minoxidil, Duasteride, and vitamins for maintenance post-surgery.

HairClone is developing cell replacement treatments to rejuvenate and generate hair follicles, and has launched a crowdfunding campaign. A user expressed skepticism about the need for crowdfunding.

The conversation is about a user's four-month hair regrowth journey using minoxidil, finasteride, and keto shampoo. The user reported significant progress, with visible thin hair appearing around the second month, which started thickening by the third month.

The user has been using finasteride for years with little regrowth and recently started using Cécred edge drops, which have significantly improved their scalp condition. Another user mentioned combining Cécred with derma stamping for better results.

The conversation discusses whether M44 had a hair transplant or uses finasteride, minoxidil, and dutasteride. Opinions vary, with some suggesting a transplant and others noting no clear signs of hair loss.